Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted arylcyclopropylacetamides as glucokinase activators

Substituted arylcyclopropylacetamides as glucokinase activators

US Patent 7576108 · Granted Aug 18, 2009

Estimated economic value: $86,124,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AHR agonists2024
Benzopiperazine compositions as BET bromodomain inhibitors2021
Compounds and compositions for inhibition of FASN2021
Compounds and compositions for inhibition of FASN2020
Benzopiperazine compositions as BET bromodomain inhibitors2020
Compounds and compositions for inhibition of FASN2019
Compounds and compositions for inhibition of FASN2019
Compounds and compositions for inhibition of FASN2019
Compounds and compositions for inhibition of FASN2019
Benzopiperazine compositions as BET bromodomain inhibitors2019
Sepiapterin reductase inhibitors2018
Benzopiperazine compositions as BET bromodomain inhibitors2016